Premium
Resistin increases islet blood flow and decreases subcutaneous adipose tissue blood flow in anaesthetized rats
Author(s) -
Danielsson T.,
Fredriksson L.,
Jansson L.,
Henriksnäs J.
Publication year - 2009
Publication title -
acta physiologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.591
H-Index - 116
eISSN - 1748-1716
pISSN - 1748-1708
DOI - 10.1111/j.1748-1716.2008.01891.x
Subject(s) - resistin , adipose tissue , medicine , endocrinology , white adipose tissue , insulin resistance , pancreas , adipokine , blood flow , islet , type 2 diabetes , insulin , diabetes mellitus
Abstract Aim: Resistin is an adipokine which has been suggested to participate in the induction of insulin resistance associated with type 2 diabetes. The aim of the present study was to investigate whether acute administration of resistin influences tissue blood perfusion in rats. Methods: Resistin was administered as an intravenous infusion of 7.5 μg h −1 (1.5 mL h −1 ) for 30 min to rats anaesthetized with thiobutabarbital. A microsphere technique was used to estimate the blood flow to six different depots of white adipose tissue (WAT), brown adipose tissue (BAT), as well as to the pancreas, islets, duodenum, colon, kidneys, adrenal glands and liver. Results: Resistin administration led to an increased blood flow to the pancreas and islets and a decrease in subcutaneous WAT and BAT. Intra‐abdominal white adipose tissue blood flow and that to other organs were not affected. Conclusion: Acute administration of resistin markedly affects the blood perfusion of both the pancreas and subcutaneous white adipose tissue depots. At present it is unknown whether resistin exerts a direct effect on the vasculature, or works through local or systemic activation of endothelial cells and/or macrophages. The extent to which this might contribute to the insulin resistance caused by resistin is yet unknown.